| 1 |
35154350 | Paeoniflorin Enhances the Sensitivity of ER-Positive Breast Cancer Cells to Tamoxifen through Promoting Sirtuin 4. | 2022 |
1 |
| 2 |
34349560 | Long Non-Coding RNA BLACAT1 Induces Tamoxifen Resistance in Human Breast Cancer by Regulating miR-503/Bcl-2 Axis [Retraction]. | 2021 |
1 |
| 3 |
34697301 | Lnc-DC promotes estrogen independent growth and tamoxifen resistance in breast cancer. | 2021 Oct 25 |
1 |
| 4 |
32210618 | Long Non-coding RNA BLACAT1 Induces Tamoxifen Resistance in Human Breast Cancer by Regulating miR-503/Bcl-2 Axis. | 2020 |
1 |
| 5 |
32215462 | Immunohistochemical assessment of symptomatic postmenopausal endometrial polyps in tamoxifen users and nonusers: a case control study. | 2020 Jan-Feb |
1 |
| 6 |
32722075 | Tamoxifen and the PI3K Inhibitor: LY294002 Synergistically Induce Apoptosis and Cell Cycle Arrest in Breast Cancer MCF-7 Cells. | 2020 Jul 24 |
2 |
| 7 |
33083299 | Synergistic Effects of Lauryl Gallate and Tamoxifen on Human Breast Cancer Cell. | 2020 Jul |
1 |
| 8 |
28431397 | Sensitization of tamoxifen-resistant breast cancer cells by Z-ligustilide through inhibiting autophagy and accumulating DNA damages. | 2017 Apr 25 |
1 |
| 9 |
28646740 | Epigallocatechin-3-gallate promotes apoptosis in human breast cancer T47D cells through down-regulation of PI3K/AKT and Telomerase. | 2017 Oct |
2 |
| 10 |
28869838 | FGFR2-Driven Signaling Counteracts Tamoxifen Effect on ERα-Positive Breast Cancer Cells. | 2017 Oct |
1 |
| 11 |
26697130 | Modulation of Tamoxifen Cytotoxicity by Caffeic Acid Phenethyl Ester in MCF-7 Breast Cancer Cells. | 2016 |
1 |
| 12 |
27664187 | Tamoxifen citrate-loaded poly(d,l) lactic acid nanoparticles: Evaluation for their anticancer activity in vitro and in vivo. | 2016 Nov |
1 |
| 13 |
25539992 | Synergy of leptin/STAT3 with HER2 receptor induces tamoxifen resistance in breast cancer cells through regulation of apoptosis-related genes. | 2015 Apr |
2 |
| 14 |
25848915 | Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression. | 2015 Feb 25 |
4 |
| 15 |
26109525 | Tamoxifen-Induced Cell Death of Malignant Glioma Cells Is Brought About by Oxidative-Stress-Mediated Alterations in the Expression of BCL2 Family Members and Is Enhanced on miR-21 Inhibition. | 2015 Oct |
3 |
| 16 |
26397135 | E2F7 overexpression leads to tamoxifen resistance in breast cancer cells by competing with E2F1 at miR-15a/16 promoter. | 2015 Oct 13 |
3 |
| 17 |
26472348 | Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy. | 2015 Oct 15 |
1 |
| 18 |
23755153 | The effect of antineoplastic drugs in a male spontaneous mammary tumor model. | 2014 |
1 |
| 19 |
24612549 | Metformin enhances tamoxifen-mediated tumor growth inhibition in ER-positive breast carcinoma. | 2014 Mar 11 |
1 |
| 20 |
24841429 | Mechanisms associated with resistance to tamoxifen in estrogen receptor-positive breast cancer (review). | 2014 Jul |
1 |
| 21 |
25081647 | Evaluation of the ability of adjuvant tamoxifen-benefit gene signatures to predict outcome of hormone-naive estrogen receptor-positive breast cancer patients treated with tamoxifen in the advanced setting. | 2014 Dec |
1 |
| 22 |
23342080 | Gene expression signatures that predict outcome of tamoxifen-treated estrogen receptor-positive, high-risk, primary breast cancer patients: a DBCG study. | 2013 |
1 |
| 23 |
23609470 | Estrogen receptor α is the major driving factor for growth in tamoxifen-resistant breast cancer and supported by HER/ERK signaling. | 2013 May |
1 |
| 24 |
23688426 | Novel tamoxifen derivative Ridaifen-B induces Bcl-2 independent autophagy without estrogen receptor involvement. | 2013 Jun 14 |
1 |
| 25 |
23845438 | BCL-2: a new therapeutic target in estrogen receptor-positive breast cancer? | 2013 Jul 8 |
1 |
| 26 |
24172207 | Priming BCL-2 to kill: the combination therapy of tamoxifen and ABT-199 in ER+ breast cancer. | 2013 |
2 |
| 27 |
22961366 | Carboplatin treatment of antiestrogen-resistant breast cancer cells. | 2012 Nov |
3 |
| 28 |
21826535 | A five-gene model predicts clinical outcome in ER+/PR+, early-stage breast cancers treated with adjuvant tamoxifen. | 2011 Oct |
1 |
| 29 |
19757172 | The growth-inhibition effect of tamoxifen in the combination chemotherapeutics on the human cholangiocarcinoma cell line QBC939. | 2010 Jul |
1 |
| 30 |
20305694 | Artemin is estrogen regulated and mediates antiestrogen resistance in mammary carcinoma. | 2010 Jun 3 |
1 |
| 31 |
20876285 | Oncogenic HER2{Delta}16 suppresses miR-15a/16 and deregulates BCL-2 to promote endocrine resistance of breast tumors. | 2010 Dec |
9 |
| 32 |
19002577 | Tamoxifen and ICI 182,780 increase Bcl-2 levels and inhibit growth of breast carcinoma cells by modulating PI3K/AKT, ERK and IGF-1R pathways independent of ERalpha. | 2009 Dec |
2 |
| 33 |
19029119 | Role of JNK1-dependent Bcl-2 phosphorylation in ceramide-induced macroautophagy. | 2009 Jan 30 |
1 |
| 34 |
19115248 | Effect of tamoxifen and retinoic acid on bradykinin induced proliferation in MCF-7 cells. | 2009 Feb 15 |
2 |
| 35 |
19173092 | An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer. | 2009 |
1 |
| 36 |
19337026 | Ceramide-induced autophagy: to junk or to protect cells? | 2009 May |
1 |
| 37 |
19661335 | Keratinocyte growth factor (KGF) regulates estrogen receptor-alpha (ER-alpha) expression and cell apoptosis via phosphatidylinositol 3-kinase (PI3K)/Akt pathway in human breast cancer cells. | 2009 Aug |
1 |
| 38 |
18676864 | The HER4/4ICD estrogen receptor coactivator and BH3-only protein is an effector of tamoxifen-induced apoptosis. | 2008 Aug 1 |
1 |
| 39 |
18928543 | A candidate molecular signature associated with tamoxifen failure in primary breast cancer. | 2008 |
1 |
| 40 |
17046747 | Overexpression of c-Myc and Bcl-2 during progression and distant metastasis of hormone-treated breast cancer. | 2007 Feb |
2 |
| 41 |
17629615 | Induction of cell death in antiestrogen resistant human breast cancer cells by the protein kinase CK2 inhibitor DMAT. | 2007 Oct 28 |
1 |
| 42 |
16413707 | Does tamoxifen therapy affect the hormone receptor expression and cell proliferation indices of endometrial polyps? An immunohistochemical comparison of endometrial polyps from postmenopausal women exposed and not exposed to tamoxifen. | 2006 Jun 20 |
1 |
| 43 |
16854582 | Effect of keratinocyte growth factor on cell viability in primary cultured human prostate cancer stromal cells. | 2006 Jul |
1 |
| 44 |
16974115 | Expression of Bcl-2 and Ki-67 in tamoxifen-associated endometrial polyps: comparison with postmenopausal polyps. | 2006 Sep |
3 |
| 45 |
15606891 | Activated JNK brings about accelerated apoptosis of Bcl-2-overexpressing C6 glioma cells on treatment with tamoxifen. | 2005 Jan |
5 |
| 46 |
15830342 | Modulation of tamoxifen sensitivity by antisense Bcl-2 and trastuzumab in breast carcinoma cells. | 2005 May 15 |
3 |
| 47 |
16267611 | Morphologic and immunophenotypic markers as surrogate endpoints of tamoxifen effect for prevention of breast cancer. | 2005 Dec |
1 |
| 48 |
14996734 | PC cell-derived growth factor mediates tamoxifen resistance and promotes tumor growth of human breast cancer cells. | 2004 Mar 1 |
1 |
| 49 |
15138474 | A prognostic index for operable, node-negative breast cancer. | 2004 May 17 |
1 |
| 50 |
15513900 | Phthalates inhibit tamoxifen-induced apoptosis in MCF-7 human breast cancer cells. | 2004 Dec |
1 |